Effect of LY2189265, a long-acting glucagon-like peptide 1...

Effect of LY2189265, a long-acting glucagon-like peptide 1 analog, on metabolic outcomes and GI events in obese patients with uncontrolled type 2 diabetes mellitus (T2DM): The EGo study.

Umpierrez, G., Blevins, T., Rosenstock, J., Cheng, C., Bastyr, E., Anderson, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Year:
2009
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/S1499-2671(09)33073-7
File:
PDF, 445 KB
english, 2009
Conversion to is in progress
Conversion to is failed